Western Blot: VCAM-1/CD106 Antibody (6G9) [NBP1-47491] - using VCAM1 mouse mAb against HUVEC (1) and EC (2) cell lysate.
Immunohistochemistry: VCAM-1/CD106 Antibody (6G9) [NBP1-47491] - Breast carcinoma, cytoplasmic staining. Image from verified customer review.
Immunohistochemistry-Paraffin: VCAM-1/CD106 Antibody (6G9) [NBP1-47491] - human lung cancer (A) and colon cancer (B) using VCAM1 mouse mAb with DAB staining.
Immunohistochemistry-Paraffin: VCAM-1/CD106 Antibody (6G9) [NBP1-47491] - human Placenta tissues using VCAM1 mouse mAb
Simple Western: VCAM-1/CD106 Antibody (6G9) [NBP1-47491] - Simple Western lane view shows a specific band for CD106/VCAM1 in 0.5 mg/ml of HUVEC lysate. This experiment was performed under reducing conditions using the ...read more
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
0.03% Sodium Azide
Ammonium sulfate precipitation
Western Blot 1:500-1:2000
Simple Western 1:1000
This VCAM1 (6G9) antibody is useful for Western blot, Immunohistochemistry on paraffin-embedded sections and ELISA.In Simple Western only 10-15 uL of the recommended dilution is used per data point.
The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Read 1 Review rated 5 using NBP1-47491 in the following applications:
VCAM1 is a member of the Ig superfamily and encodes a cell surface sialoglycoprotein expressed by cytokine-activated endothelium. This type I membrane protein mediates leukocyte-endothelial cell adhesion and signal transduction, and may play a role in the development of artherosclerosis and rheumatoid arthritis. Two alternatively spliced transcripts encoding different isoforms have been described for this gene. Tissue specificity: Expressed on inflamed vascular endothelium, as well as on macrophage-like and dendritic cell types in both normal and inflamed tissue.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.